Could this new HIV -drugs -end agents? – Better2 Know Blog

Could this new HIV -drugs -end agents? – Better2 Know Blog

HIV has been a scourge around the world for decades. Although amazing progress has been made in prevention and treatment, it still affects millions of people around the world and can lead to many negative health results.

But there is hope that a new medicine can help many people who live with this permanent condition.

HIV can be effectively treated with the right care. But first you have to know your sexual health status. Our HIV -Thuistestkit gives you fast, accurate test results from the comfort of your own home.

What is this new medicine?

The World Health Organization (WHO) has published updated guidelines Support for the use of Lenacapavir, a new injectable medicine, as a way to help patients with a high risk.

The drug is intended to be conceived as a two -year injection, and acts as an extra prevention option for people who run the risk of running out of HIV, especially in risky areas. The guidance recommends the use of Lenacapavir in combination with other HIV prevention drugs, such as Tenofovir Disoproxil Fumarate (TDF) and other forms of pre-blot statement prophylaxsis (prep).

This new guidance is supported by two multicenter, double -blind, randomized, active controlled studies.

These studies showed that Lenacapavir resulted in a significant reduction in HIV -acquisition and high treatment effectiveness compared to other daily oral prep drugs such as TDF. More research is needed to know how this medicine can influence certain populations, such as sex workers, people who inject drugs and detained individuals.

Lenacapavir did not show any adverse results when administered to pregnant persons and is not associated with negative birth results. The studies also showed no evidence that Lenacapavir had meaningful interactions with hormonal contraception or gender -confirming hormone therapy.

Does it work for other STDs?

Lenacapavir is specifically designed for HIV. Collected evidence during these studies found comparable transfer percentages of other infections compared to other PrEP recipients.

How is it rolled out?

The US government has announced plans to invest in Lenacapavir. The Ministry of Foreign Affairs wants to reach to 2 million people with the medicine by 2028, hoping that it will help save hundreds of thousands of lives. In the coming months, the US will work with countries with the largest HIV/AIDS epidemics to develop roll-out strategies with a focus on preventing mother-on-child transmission.

This announcement comes as a blessing for many researchers and specialists, who have expressed concern about recent cuts on global financing for health and research initiatives.

The American financial obligation is a partnership between the Global Fund and Gilead Science, a Biopharma company established in California that makes the medicine.

For decades, the US had been the world leader in combating HIV. Pepfar (the Emergency Plan of the President for Aids for AIDS) usually had strong support from all political parties. After it was founded in 2003, Pepfar had invested more than $ 120 billion worldwide to help fight HIV and AIDS. It was also an important role in the development of a daily preppil to prevent infections.

When is the medicine available?

The logistics of the rollout of the medicine is still determined. The hope among health officials is that the medicine could be in Africa in Africa by the end of this year. However, African countries must first make the medicine green light light.

After the first version of the medicine has been rolled out, a cheaper generic form of the medicine will soon be available. Gilead Sciences shared the Lenacapavir license and information about how you can reach various other manufacturers. Generic versions of the drug will probably not be available until 2027 because of the time needed to start production and perform tests.

Last thoughts

Chairman of Better2 Know, Mike Asher, had this to say about the last breakthrough:

We welcome this breakthrough of Better2 Know in HIV treatment. This new medicine has the potential to save many lives in areas where this harmful infection is still spreading. We hope that this will lead to further progress in treatment, so that HIV can be completely eradicated. We encourage everyone who worries that they have HIV to reach out and be tested and treated. It is always better to know your STD status so that you can get the treatment you need. “

If you are worried that you may have an STD, Better2 Know is here to help. Soa’s can spread from person to person without ever showing symptoms. Book an STD test today at a sexual health care clinic in your area.

A person who looks at a content generated by mobile phone can be incorrect.

Don’t leave your sexual health to chance.





#HIV #drugs #agents #Better2 #Blog

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *